Fingerprint
Dive into the research topics of 'Gemtuzumab ozogamicin reduces relapse risk in FLT3/ITD acute myeloid leukemia: A report from the children's oncology group'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Katherine Tarlock, Todd A. Alonzo, Robert B. Gerbing, Susana C. Raimondi, Betsy A. Hirsch, Lillian Sung, Jessica A. Pollard, Richard Aplenc, Michael R. Loken, Alan S. Gamis, Soheil Meshinchi
Research output: Contribution to journal › Article › peer-review